ArticleAnnals of clinical microbiology and antimicrobials2016

A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin.

Abrar K Thabit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.